Skip to content

Opening book details…

About this Biochemistry, Genetics and Molecular Biology article

Enzalutamide for treatment of CRPC: Rationale for sequencing and potential clinical biomarker for resistance by Lochrin, Sarah E; Figg, William D; Finn, Stephen P is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Lochrin, Sarah E; Figg, William D; Finn, Stephen P
Publisher
Landes Bioscience; Informa UK Limited (ISSN 1538-4047)
Published
2015
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Lochrin, Sarah E; Figg, William D; Finn, Stephen P

Browse all works by Lochrin, Sarah E; Figg, William D; Finn, Stephen P